Assertio Blasts Rival's Bid To Shorten Nucynta Injunction
Alkem Laboratories shouldn't be allowed to sell a generic version of Assertio Therapeutics' opioid painkiller Nucynta ER three years earlier than an injunction allows after changing its drug's label to dodge...To view the full article, register now.
Already a subscriber? Click here to view full article